Uncategorized Archives - Page 33 of 221

TuesdayFeb 01, 2022 2:20 pm

The Alternative Products Expo To Offer Important Networking Opportunities

The Alternative Products Expo arrives in Fort Lauderdale March 11-13 to feature the scope and potential of all innovative products and services of the alternative products ecosystem. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one roof, while offering a fun and exciting experience. Having conducted its CBD shows in the top cities of America, ZJ Events is all set to host an exciting new event in Fort Lauderdale, The Alternative Products Expo. The alternative product category includes herbal products, mood enhancers, cannabis derivatives, vape products, energy…

TuesdayFeb 01, 2022 1:41 pm

InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Recent Access of Manufacturing Technologies Now Give It the Potential to Synthetically Produce Rare Cannabinoids at Large Scale, a Unique and Coveted Position in the Rapidly Developing Rare Cannabinoid Space

Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefits InMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable to rare cannabinoids As a result of this acquisition, InMed, already a leader in the production of rare cannabinoid CBC, is now in the unique and highly desired position to undertake large-scale production of other rare cannabinoids, with applications as wide as the current CBD market The company plans to launch new rare cannabinoid products in the first half of…

MondayJan 31, 2022 12:38 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Offers a Glimpse into Company’s Unique Technology and Operations on EDGE Podcast

Chris Bunka, the Chairman and CEO of Lexaria, featured on the EDGE podcast hosted by Brandon C. White He provided insight into his background, professional philosophies, and Lexaria’s operations, with a focus on the company’s patented DehydraTECH(TM) technology Mr. Bunka also advised small companies and entrepreneurs, citing the importance of understanding the competitive environment Chris Bunka, the Chairman and Chief Executive Officer (“CEO”) of Lexaria Bioscience (NASDAQ: LEXX), was recently featured on episode 234 of the EDGE Podcast. Hosted by Brandon C. White, an Angel Investor and Entrepreneur, Mr. Bunka shared insights into his professional journey while also sharing what…

FridayJan 28, 2022 10:00 am

Flora Growth Corp. (NASDAQ: FLGC) Names Cannabis Pioneer as Colombian Facility Advisor as Company Prepares for International Growth

Canada-based Flora Growth Corp. operates cannabis cultivation and extraction processes in-house at its Cosechemos lab and growth facility in central Colombia The company has been building a portfolio of cannabis and wellness products and obtaining a variety of licenses and GMP certifications as it establishes partnerships to economically distribute its portfolio worldwide Flora Growth recently announced the addition of pioneering cannabis genetics innovator Derek Pedro in an advisory role for its Cosechemos facility Pedro will help the company build on its more-than-190 product offerings with cannabis flower cultivation and distribution Cannabis cultivator and worldwide cannabidiol (“CBD”) brand builder Flora Growth…

ThursdayJan 27, 2022 11:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Emphasizes Oral Cannabinoid Delivery Benefits Following SARS-CoV-2 Study

The study is available for public viewing and is entitled “Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants” (https://cnw.fm/Aq36i) Dr. Richard van Breeman, who headed the independent study, explained that smoking and vaping cannabinoids are ineffective against preventing SARS-CoV-2, whereas oral delivery methods are effective Lexaria has been studying and researching the oral delivery of compounds using its patented DehydraTECH(TM) technology, which enhances bioavailability and absorption, requiring less heat than smoking or vaping and leaving the cannabinoid compounds undamaged Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, commented on an independent January 10 study headed…

ThursdayJan 27, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Gains Full Cannabis Licensing to Rise in Michigan’s Developing Recreational Use Market

Multi-state cannabis operator Red White & Bloom Brands is developing opportunities strategically in sizable cannabis markets such as Michigan, Florida, Illinois, California, Arizona, Oklahoma and Massachusetts The company recently announced it has secured full licensing for manufacturing both medical and adult use cannabis products in Michigan, one of its key markets Red White & Bloom has closed on a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in the state In Florida, Red White & Bloom settled a CAD$5.1 million debt at a favorable conversion price, granting the company an accounting gain of approximately CAD$2.3 million As Michigan…

WednesdayJan 26, 2022 12:15 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging on the Growing Cannabinoid-Based Pharmaceuticals Market

The global cannabinoid-based pharmaceuticals market is projected to be valued at $50 billion by 2029 InMed is leading the industry, laying down the foundation in manufacturing and clinical development of rare cannabinoids It is shedding light on the potential of rare cannabinoids and laying the groundwork on how to tap into the industry’s growth It is projected that by 2025, the global cannabis market will be valued at around $146 billion, up from just $20.47 billion in 2020. This sector is experiencing tremendous growth, particularly considering that there are over one hundred known cannabinoids, including rare ones that are quickly…

MondayJan 24, 2022 1:01 pm

Flora Growth Corp. (NASDAQ: FLGC) Kicks off 2022 with Successful First Cannabis Extraction at new Colombia Facility, the Appointment of Tim Leslie as Advisory Board Chairman, and 360 Financial Inc.’s FLGC stock purchase

Flora Growth just announced the production of its first batch of crude oil through its newly constructed facility in Colombia The company has also initiated the EU-GMP certification process that will allow it to target international medical cannabis markets Flora Growth also announced the appointment of Tim Leslie as Chairman of its newly established Advisory Board Mr. Leslie will play a key role in advising the company on how best to navigate the regulatory framework of building a truly global company 360 Financial, Inc. announced the purchase of 13,162 Flora Growth shares as of Q4 2021 Flora Growth (NASDAQ: FLGC)…

ThursdayJan 20, 2022 1:03 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Great Start to its 2022 R&D Programs Following Independent Review Board Approval

Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatment The stage is also set for other R&D programs for the 2022 calendar year, including HOR-A22-1, DEM-A22-1, RHEUM-A22-1 and DIAB-A22-1 All of these 2022 R&D programs are fully funded, with Lexaria having raised approximately $15 million over the 2021 calendar year Lexaria believes that these programs will build significant value for its stakeholders and pursue policies for substantial improvements to human health In late 2021, Lexaria Bioscience (NASDAQ: LEXX) announced several new and ongoing R&D programs for its patented DehydraTECH(TM) technology. While making the announcement,…

TuesdayJan 18, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) in 2021, Year in Review

RWB marked 2021 with strategic acquisitions, with the most notable of them being Acreage Holdings Inc. and a 45,000 square foot greenhouse in Apopka, Florida These strategic investments would see the company steadily grow its revenue, marking a 93% year-over-year growth by Q3 The year also marked notable appointments, including Ryan Costello and Colby De Zen, both into the company’s Board of Directors RWB is confident that the foundations laid down in 2021 will play a vital role in the company’s growth in 2022, as well as creating shareholder value Since its inception, Red White & Bloom Brands (CSE: RWB)…

News and publishing service for hemp related companies

Contact us: 512.354.7000

Category: Uncategorized